血浆致动脉硬化指数在冠心病中的应用及研究进展  

Application and Research Progress of Atherogenic Index of Plasma in Coronary Atherosclerotic Heart Disease

作　　者：赵淑丽[1] 楚天舒[1] 

机构地区：[1]昆明医科大学第二附属医院心血管内科,云南昆明650000

出　　处：《心血管病学进展》2015年第6期721-725,共5页Advances in Cardiovascular Diseases

摘　　要：冠状动脉粥样硬化性心脏病是一种严重威胁人类健康的常见病、多发病,在发达国家已成为人口死亡的主要原因。血脂异常是动脉粥样硬化的最重要危险因素,经典单纯单项血脂指标异常已不能完全解释和预测心血管病发病和转归的规律,血浆致动脉硬化指数作为一项新的血脂综合指标,可以进行初步预测冠状动脉病变,并早期诊断及评估冠心病的发生,具有较强的应用及临床实用价值,明显优于现有的传统单项血脂指标。现就血浆致动脉硬化指数在冠心病中的应用及研究进展予以综述。Coronary atherosclerotic heart disease is a serious threat to human health of common disease,frequently-occurring disease,has become the leading cause of death in population in developed countries. Dyslipidemia is the most important risk factor for atherosclerosis. Traditional single index of lipid abnormalities can not fully explain and predict cardiovascular disease incidence and the law of outcome.Atherogenic index of plasma as a new lipid comprehensive index,with strong application and clinical practical value,is superior to the existing traditional single blood fat index,can conduct a preliminary prediction of coronary aretery lesions,and early diagnosis and assessment of the occurrence of coronary heart disease. Here is to review the application and research progress of atherogenic index of plasma in coronary atherosclerotic heart disease.

关 键 词：血浆致动脉硬化指数 血脂异常 冠心病 

分 类 号：R541.4[医药卫生—心血管疾病]